Table 6 Logistic regression for factors affecting SD domains among chronic HCV cases.

From: Sexual dysfunction among Egyptian men with chronic hepatitis C in the post elimination era prevalence and associated factors

Factors

β

SE

P

AOR (95% CI)

Desire Dysfunction (DD)

Hepatocellular carcinoma (HCC)

2.517

0.501

< 0.001*

12.391 (4.639–33.093)

Age ≥ 50.0

1.610

0.161

< 0.001*

5.003 (3.652–6.854)

Child score

0.028

0.008

< 0.001*

1.028 (1.013–1.044)

Tramadol

-2.242

0.288

< 0.001*

0.106 (0.060–0.187)

Erectile Dysfunction (ED)

Spironolactone

6.909

0.728

< 0.001*

1001.04 (240.459-4167.435)

Age ≥ 50.0

1.651

0.271

< 0.001*

5.210 (3.063–8.863)

Diabetes mellitus (DM)

1.357

0.321

< 0.001*

3.885 (2.069–7.295)

Beta-blocker

1.075

0.276

< 0.001*

2.929 (1.706–5.028)

Child score

0.082

0.038

0.032*

1.085 (1.007–1.170)

Tea

-2.507

0.291

< 0.001*

0.082 (0.046–0.144)

Premature Ejaculation (PE)

HCC

2.197

0.752

0.003*

8.994 (2.061–39.247)

Age ≥ 50.0

2.025

0.305

< 0.001*

7.577 (4.171–13.763)

DM

1.204

0.336

< 0.001*

3.332 (1.724–6.440)

Child score

0.576

0.050

< 0.001*

1.780 (1.614–1.962)

Beta-blocker

0.565

0.266

0.033*

1.760 (1.045–2.962)

Age 40–49 years

0.530

0.209

0.011*

1.700 (1.128–2.562)

Tramadol

-0.798

0.298

0.007*

0.450 (0.251–0.807)

Tea

-4.975

0.359

< 0.001*

0.007 (0.003–0.014)

  1. β: Regression coefficient. SE: Standard error. AOR: Adjusted Odds ratio. CI: Confidence interval. HCC: hepatocellular carcinoma; DM: diabetes mellitus. *Significant at p < 0.05.